A case for developing North-South partnerships for research in sickle cell disease
- 1 February 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (3) , 921-923
- https://doi.org/10.1182/blood-2004-06-2404
Abstract
For a better understanding of the pathophysiology and mechanisms of phenotypic diversity of sickle cell disease, and for the improvement of its management globally, there is a strong case for developing sustainable research partnerships between rich and poor countries.Keywords
This publication has 18 references indexed in Scilit:
- Genomics and Global Health: Time for a ReappraisalScience, 2003
- Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African settingBlood, 2003
- Tapping the power of small institutionsNature, 2003
- Genetic variability in response to infection: malaria and afterGenes & Immunity, 2002
- Nitric oxide therapy in sickle cell diseaseSeminars in Hematology, 2001
- Common West African HLA antigens are associated with protection from severe malariaNature, 1991
- Prophylaxis with Oral Penicillin in Children with Sickle Cell AnemiaNew England Journal of Medicine, 1986
- Causes of death in sickle-cell disease in Jamaica.BMJ, 1982
- Benign sickle cell disease in Saudi Arabia: survival estimate and population dynamicsClinical Genetics, 1979
- Protection Afforded by Sickle-cell Trait Against Subtertian Malarial InfectionBMJ, 1954